Updated Analysis of an Open-Label, Phase 2 Study of Blinatumomab As Second Salvage Therapy in Adults with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

被引：2
|
作者：
Coyle, Luke
Morley, Nicholas J.
Rambaldi, Alessandro
Mason, Kylie D.
Verhoef, Gregor
Furness, Caroline
Desai, Rajendra
Mergen, Noemi
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-141117
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Biomarker Analysis of a Phase Ia/Ib Open-Label, Multicentre Study of Tiragolumab or Tiragolumab plus Rituximab in Patients with Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL)
    Ruppert, Shannon
    Cuchelkar, Vaikunth
    Meng, Raymond
    Cho, Eunpi
    Lear, Sean
    Wong, Cheryl Victoria
    Raval, Aparna
    Nouet, Yann
    BLOOD, 2021, 138
  • [22] Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
    Ohmachi, Ken
    Ando, Kiyoshi
    Ogura, Michinori
    Uchida, Toshiki
    Itoh, Kuniaki
    Kubota, Nobuko
    Ishizawa, Kenichi
    Yamamoto, Joji
    Watanabe, Takashi
    Uike, Naokuni
    Choi, Ilseung
    Terui, Yasuhito
    Usuki, Kensuke
    Nagai, Hirokazu
    Uoshima, Nobuhiko
    Tobinai, Kensei
    CANCER SCIENCE, 2010, 101 (09) : 2059 - 2064
  • [23] Phase 1b open-label study of loncastuximab tesirine in combination with other anticancer agents in patients with relapsed/refractory B-cell non-Hodgkin lymphoma (LOTIS-7).
    Hess, Brian T.
    Solh, Melhem M.
    Gandhi, Mitul
    Wang, Ying
    Qin, Yajuan
    Yu, Eric
    Zinzani, Pier Luigi
    Collins, Graham P.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [24] Phase 1b Open-Label Study of Loncastuximab Tesirine in Combination With Other Anticancer Agents in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)
    Ayers, Emily C.
    Depaus, Julien
    Offner, Fritz
    Hu, Marie
    Okada, Craig
    Urban, Andrzej
    Niewiarowski, Andrew
    Rave, Erica
    Laughlin, Mary
    Alderuccio, Juan Pablo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S474 - S474
  • [25] Choosing the appropriate salvage therapy for B-cell non-Hodgkin lymphoma
    Hashmi, Hamza
    Hamadani, Mehdi
    Awan, Farrukh T.
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (15) : 1631 - 1634
  • [26] Lisocabtagene maraleucel for relapsed or refractory large B-cell non-Hodgkin lymphoma
    Mohty, Razan
    Vanegas, Yenny Moreno
    Chavez, Julio C.
    Kharfan-Dabaja, Mohamed A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (02) : 121 - 126
  • [27] An Open-Label, Phase I Study of R-CVP in Combination with Inotuzumab Ozogamicin in Patients with Relapsed/Refractory CD22-Positive B-Cell Non-Hodgkin Lymphoma
    Ogura, Michinori
    Uchida, Toshiki
    MacDonald, David A.
    Hatake, Kiyohiko
    Davies, Andrew
    Sangha, Randeep
    Crump, Michael
    Thieblemont, Catherine
    Ishibashi, Taro
    Hua, Steven
    Paccagnella, Luisa
    Vandendries, Erik R.
    Kobayashi, Yukio
    Tobinai, Kensei
    BLOOD, 2011, 118 (21) : 1587 - 1587
  • [28] Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphoma
    Hamadani, Mehdi
    Radford, John
    Carlo-Stella, Carmelo
    Caimi, Paolo F.
    Reid, Erin
    O'Connor, Owen A.
    Feingold, Jay M.
    Ardeshna, Kirit M.
    Townsend, William
    Solh, Melhem
    Heffner, Leonard T.
    Ungar, David
    Wang, Luqiang
    Boni, Joseph
    Havenith, Karin
    Qin, Yajuan
    Kahl, Brad S.
    BLOOD, 2021, 137 (19) : 2634 - 2645
  • [29] A Phase I Study of Ibrutinib and Lenalidomide in Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma
    Christian, Beth
    Kuruvilla, John
    Smith, Sonali
    Porcu, Pierluigi
    Ruppert, Amy S.
    Byrd, John C.
    Grever, Michael R.
    Blum, Kristie A.
    BLOOD, 2014, 124 (21)
  • [30] Results of a Phase I Study of Obinutuzumab, Venetoclax, and Lenalidomide in Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma
    Christian, Beth A.
    Huang, Ying
    Ayyappan, Sabarish
    Baiocchi, Robert A.
    Brammer, Jonathan E.
    Epperla, Narendranath
    Jaglowski, Samantha
    William, Basem M.
    Awan, Farrukh T.
    Maddocks, Kami J.
    Blum, Kristie A.
    BLOOD, 2019, 134
12345